News & Events

Article Types

Sort by year

Cellarity Publishes Framework for Discovery of Cell State-Correcting Medicines in Science

Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the Treatment of Sickle Cell Disease

Ted Myles Joins Cellarity as Chief Executive Officer

Biotech2050 Podcast: Cellarity CEO Fabrice Chouraqui on how AI/ML are Revolutionizing Drug Discovery

Cellarity Appoints Percy Carter, MBA, Ph.D., as Member of Board of Directors

Cellarity Appoints Head of Platform to Advance Vision for Novel Drug Creation

Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases

Cellarity Announces the Expansion of Its Partnership with Novo Nordisk to Discover and Develop a Novel Treatment in Metabolic Steatohepatitis (MASH) Using Its Innovative Platform

Cellarity to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Cellarity Named a Top Place to Work for 2023 by The Boston Globe

Load More